IRVINE, Calif.--(BUSINESS WIRE)--Pharmacogenomics research and development innovator PharmaGenoma, Inc. and its subsidiary HairDX, LLC (www.hairdx.com), pioneers genetic tests for predicting the risk of male and female hair loss, today announced an exclusive agreement with Aderans Company Limited of Tokyo to introduce the breakthrough tests in Japan starting on March 1, 2009. The HairDX test collection kit is listed with Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) as a Class I medical device.
